Furthermore, the functional interplay of NOX4 and IL-6 in enhancing growth and survival of NSCLC cells in vivo was also confirmed by Ki67 (the biomarker to evaluate tumor proliferation) (Fig. 8C) and TUNEL staining analysis (evaluation of tumor apoptosis) (Fig. 8D). The gene discussed is NOX4; the disease is non-small cell lung carcinoma.